Table 3.

Effect of Unfractionated Heparin and the LMWH, Tinzaparin, on Dynamic Tetracycline-Based Measurements

LabeledMineralBone Formation
Surface (%)AppositionRate Bone-Surface-
Rate (μm/d)Based (μm3/μm2/d)
Baseline  —   —   —  
Control 9.4 ± 2.2 1.10 ± 0.14 10.38 ± 2.61 
LMWH (0.5 U/g) 6.3 ± 1.1 1.00 ± 0.09 6.30 ± 1.183-150 
LMWH (1.0 U/g) 6.0 ± 0.93-150 0.98 ± 0.19 5.86 ± 0.943-150 
Heparin (0.5 U/g) 5.5 ± 0.93-150 1.03 ± 0.18 5.70 ± 1.033-150 
Heparin (1.0 U/g) 4.8 ± 0.73-150 0.99 ± 0.14 4.76 ± 0.783-150 
LabeledMineralBone Formation
Surface (%)AppositionRate Bone-Surface-
Rate (μm/d)Based (μm3/μm2/d)
Baseline  —   —   —  
Control 9.4 ± 2.2 1.10 ± 0.14 10.38 ± 2.61 
LMWH (0.5 U/g) 6.3 ± 1.1 1.00 ± 0.09 6.30 ± 1.183-150 
LMWH (1.0 U/g) 6.0 ± 0.93-150 0.98 ± 0.19 5.86 ± 0.943-150 
Heparin (0.5 U/g) 5.5 ± 0.93-150 1.03 ± 0.18 5.70 ± 1.033-150 
Heparin (1.0 U/g) 4.8 ± 0.73-150 0.99 ± 0.14 4.76 ± 0.783-150 

Rats were injected with either unfractionated heparin or LMWH, at a concentration of either 0.5 or 1.0 U/g for 32 days. One group of rats also served as a control and were given equivalent volumes of saline in place of heparin. All animals received intraperitoneal injections of tetracycline at 10 and 3 days before sacrifice. The percentage of labeled surface covering the cancellous bone surface was then determined as described in Materials and Methods.

F3-150

P < .005 when compared with control values.

Close Modal

or Create an Account

Close Modal
Close Modal